Xylem Inc. (XYL)
NYSE: XYL · Real-Time Price · USD
106.96
+0.41 (0.38%)
At close: Sep 11, 2026, 4:00 PM EDT
107.62
+0.66 (0.62%)
After-hours: Sep 11, 2026, 7:44 PM EDT
← View all transcripts

Earnings Call: Q2 2014

Jul 29, 2014

Operator

Welcome to the Xylem second quarter 2014 earnings conference call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions following the presentation. If you would like to ask a question at that time, please press star one on your touch-tone phone. If at any point your question has been answered, you may remove yourself from the queue by pressing the pound key. We ask that you please pick up your handset to allow optimal sound quality. Lastly, if you should require operator assistance, please press star zero. I would now like to turn the call over to Phil DeSousa, Vice President of Investor Relations.

Phil De Sousa
VP of Investor Relations, Xylem

Thank you, Jackie. Good morning, everyone, and welcome to Xylem's second quarter 2014 earnings conference call. With me today are Chief Executive Officer, Patrick Decker, and Chief Financial Officer, Michael Speetzen. They will provide their perspective on Xylem's quarterly results and discuss the full-year outlook for 2014. Following our prepared remarks, we will address questions related to the information covered on the call. At that time, I'll ask that you please keep to one question and a follow-up and then return to the queue, so we will have enough time to address everyone on the call today. We anticipate that the call will last approximately one hour. As a reminder, this call and our webcast are accompanied by a slide presentation available in the Investors section of our website at www.xyleminc.com. A replay of today's call will be available until midnight on August 13th.

Please note that the replay number is 404-537-3406, and the confirmation code is 66840967. Additionally, the call will be available for playback via the Investors section of our website under the heading Presentations. All references today will be on an adjusted basis unless otherwise indicated, and the non-GAAP financials are reconciled for you in the appendix section of the presentation. With that said, please turn to Slide 2. We will make some forward-looking statements on today's call, including references to future events or development that we anticipate will or may occur in the future. These statements are subject to future risks and uncertainties, such as those factors described in Xylem's most annual report on Form 10-K and in subsequent reports filed with the SEC.

Please note that the company undertakes no obligation to update any forward-looking statements publicly to reflect subsequent events or circumstances, and actual events or results could differ materially from those anticipated. Now, please turn to Slide 3, and I'll turn the call over to our CEO, Patrick Decker.

Patrick Decker
CEO, Xylem

Thanks, Phil, and thank you all for joining us this morning. Today, we announced our second quarter 2014 results. In a moment, I'll give you some headline comments and share my perspective. I'll then provide an update on our 2014 goals and some additional color on my observations since our last call. I'll then turn it over to Mike to share more details on this quarter's performance before I cover our full-year outlook. Let's get started. I'm proud of our teams and encouraged with what we achieved this quarter. Despite mixed levels of recovery in our key end markets, revenue growth was up 4% organically, and coupled with the execution of cost savings initiatives, drove an operating margin expansion of 220 basis points and a 33% improvement in earnings per share. This marks the fourth consecutive quarter of revenue and earnings growth, as well as margin expansion.

Second quarter orders were just over $1 billion. While the headline organic growth registers 1% in orders, the overall total is a new record, passing the previous mark set during last year's second quarter. As a result, we also exit the quarter with record backlog, just over $800 million, up approximately 8% versus the prior year. Just a few additional comments. Relative to last year, we have a 5% increase in backlog that is shippable in the second half of this year and a more impressive 18% increase for next year. I'm encouraged by these results, but I also must point out that some of our end markets remain challenged and are still slow to recover, and our business remains predominantly short cycle. All of this adds up to the fact that we still have a lot of work to do to deliver 2014.

Beyond the short cycle business, we are continuing to focus on building our longer cycle backlog. As an example, we recently won a bid for a $9 million water filtration system, which will address the critical water shortage in São Paulo, Brazil. This is exciting because it's the largest award we have ever won in the region, and it's a referential win with an important key account for us. We believe we'll be able to do more to help address the significant water crisis Brazil is facing, and we expect there will be more opportunities in the country for Xylem. In the Middle East, we had another referential win, a $7 million order to expand and upgrade existing ozone systems at the Tubli Wastewater Treatment Plant in Bahrain. These are just two examples of the opportunities that we think are plentiful in emerging markets.

We intend to find and pursue these opportunities and expect that the breadth of our product line, the service proposition we offer, and the skills and support of the Xylem teams will help us to bring in many more of these types of significant project wins. I'm generally pleased with the performance we're seeing in emerging markets, I firmly believe the opportunity is greater. During the quarter, I spent two weeks visiting several customers and our facilities and management teams in Asia. I left very encouraged by the prospects of our businesses there. It's clear to me that there is far more opportunity to grow our business and more opportunity to localize manufacturing and research and development, which will ultimately drive innovation, which can support the local markets but can also be leveraged globally. Experience tells me this does not happen overnight. It's a multi-year process.

I am excited by what I see and by what I believe lies ahead for us. Tonight, I leave for South America, where I will spend the next week or so meeting with customers and will be assessing and evaluating new opportunities in that region. With that said, let me get back to the quarter. Second quarter revenue was just over $1 billion and includes favorable contributions across most regions, including 11% organic growth in emerging markets. Let me give you some color as to how the quarter progressed. We started with flat year-over-year revenue in April, which was short of our expectations. As a result, the team focused on ensuring we would deliver every scheduled order we had on hand, working hard to reduce delinquent shipments.

As the quarter progressed, we did see some market improvement and also ended up seeing some business shift into the second quarter that we originally expected to deliver in the third quarter. No heroics or big projects to note specifically, but rather strong focus and execution by the teams. Operating income increased 28% year-over-year, and operating margin expanded 220 basis points, reflecting strong incremental margin performance and the significant impact of cost reduction actions. We generated free cash flow of $50 million, primarily reflecting higher income and typical seasonality. Finally, on the capital employment front, we opportunistically repurchased an additional $50 million in common stock, bringing our full-year repurchases up to $100 million, and our total return to shareholders up to $147 million, including dividends.

To wrap up the second quarter results, volume growth and improved operating performance drove earnings per share of $0.48, up 33% over the prior year. As you already read this morning, we are raising the lower end of our EPS guidance, reflecting both our first half performance and our outlook for the second half. We will cover this in more detail on the call. Turning to slide four. Before Mike Speetzen covers off more details on the quarter, I'm going to take a few minutes and talk about how we're doing on the 2014 goals we outlined, as well as some strategic priorities that will ultimately improve our business over the long term. Our results continue to show we are moving the company in the right direction.

Based on our first half performance and outlook over the balance of the year, we are on track to deliver our 2014 financial commitments. We expect to achieve nearly $4 billion in revenues. In terms of operating income, we expect margin to improve to the 13% range and expect EPS in the range of $1.90-$2, which would represent 14%-20% growth. We continue to make progress around integrating our commercial front end, and while we still have much work to do to optimize our structure, I am confident that over the long term, this investment will help us accelerate and achieve above-market growth. We also continue to make progress on our portfolio and capital deployment processes. Creating shareholder value requires a balanced and disciplined capital deployment strategy. Earlier this month, we announced the divestiture of our U.K.-based oil and gas valve business for approximately $30 million.

This transaction resulted from a continuous portfolio review process. I think it is well understood that this is a good business, but it was not scalable within our portfolio. Over the long term, it would compete for valuable capital and human resources with other parts of our business that are more aligned with our core strategies. It made sense to sell the business. Given where we are in the cycle, the timing of this transaction maximizes shareholder value and allows us to invest even more in organic and inorganic growth opportunities that are more attractive and strategic to Xylem. We continue to focus on optimizing our cost structure. I believe we can realize more benefits and will increase our productivity by developing stronger global strategic sourcing and Lean Six Sigma capabilities. We are working to build a mindset and a culture centered on continuous improvement.

This is not just about the opportunity inside the four walls of our factories, but across all aspects of our value chain and business. That's easier said than done. It will take considerable time to make this a cornerstone of our business. We are already making progress, beginning with global sourcing. I believe that by centralizing this function, we'll be able to move faster and drive more savings. As a first step, we've just hired a global strategic sourcing leader whose sole focus will be to optimize the savings we can achieve by leveraging the consolidated global purchasing power of the entire company. As I said, this is a first step.

We will also be further centralizing our continuous improvement efforts and leadership to ensure that we have the right people, processes, and tools in place to drive productivity to new levels and to help facilitate the change management programs that are required to accelerate this and make it sustainable. We need to be consistent and confident in our decisions and focused on our execution. I'll wrap up with the same message that I delivered to you last quarter. It's not lost on me or any of my team that we faced and continue to face significant challenges, I am convinced that we are well on our way to overcoming them. I don't expect that road ahead will be entirely smooth, nor should you. I am excited about the direction we're heading, confident in the future, and very excited to be leading this team.

With that, let me turn the call over to our CFO, Mike Speetzen, to walk you through the results and the company's financial position in more detail. Mike?

Mike Speetzen
CFO, Xylem

Thanks, Patrick. Please turn to slide five. We generated just over $1 billion in revenues, up 5% from the prior year and up 4% on an organic basis. From an end market perspective, we saw strength in public utility and industrial, partially offset by commercial. The public utility end market was up 7%, driven primarily by continued infrastructure investment in emerging markets. Europe was also up, thanks to a healthy northern region, coupled with a relatively easy prior year comp. The U.S. was flat year-over-year. Industrial was up 5%, with growth across most regions. It is worth reminding everyone that we serve a wide variety of industrial customers and that we supply this market with applications from both of our segments. As expected, the largest contribution from this segment was attributable to growth in the U.S. and emerging markets.

While we are excited to see solid growth posted in our two largest end markets, we were, however, disappointed with the 3% decline in commercial. The trend here remains the same given our overweight position in the U.S. institutional building market. Here we continue to see pressure as construction and the recovery continue to lag the broader commercial market. I will cover off more specifics by segment, but generally speaking, we saw strong growth from emerging markets up 11% and modest growth of 3% and 1% in Europe and the U.S. respectively. Operating income of $125 million was up $27 million or 28% over last year, and operating margins increased 220 basis points to 12.4%. The second quarter's performance was driven by the increase in organic volume and savings from cost reduction initiatives across our businesses.

Cost reductions totaled $39 million and including approximately $12 million of restructuring savings, with the balance coming from sourcing and Lean initiatives. Partially offsetting these tailwinds was inflation of approximately 2% and unfavorable price and mix within our Water Infrastructure segment. Incremental margins were 60%, including the benefit from restructuring on unfavorable foreign exchange. Excluding these items, incremental margins were still strong at roughly 40%. Solid top line and operational performance, coupled with strong execution against our cost reduction initiatives, resulted in EPS of $0.48, up 33% versus the prior year and slightly better than we originally anticipated. Core operations drove the year-over-year EPS improvement, contributing $0.13, driven by organic volume growth combined with execution on productivity and cost management, including restructuring savings of $0.05. Now let me provide more detail on each of our reporting segments. Please turn to slide six.

Water Infrastructure reported revenue of $636 million, up 7%. We experienced organic growth in all of our applications. Regionally, we saw the most significant growth come from emerging markets, which were up 16%. We also posted mid-single-digit growth in both Europe and the U.S. I would summarize our revenue performance as follows. Transport revenue was up 6%, driven by public utility infrastructure investment across most regions and dewatering strength in the U.S. This was driven by an increase in hydraulic fracturing rental and related services and an increase in general demand for dewatering equipment. Treatment revenue was up 15% due to emerging market strength and the timing of project deliveries. Europe was also up, driven by demand for biogas mixers ahead of the expiration of certain German government incentives. Finally, test was up 5%, driven by growth in both the U.S. and Europe.

Operating income of $82 million was up $19 million or 30% over last year, and operating margins increased 230 basis points to 12.9%. Performance was driven by the increase in organic volume and savings from cost reductions, which totaled $26 million and included approximately $9 million of restructuring savings, with the balance coming from sourcing and Lean initiatives. Partially offsetting these tailwinds was inflation of approximately 2% and unfavorable price and mix. Mix was a considerable headwind driven by lower dewatering rental for disaster recovery activities like Superstorm Sandy and increased project deliveries in emerging and developed regions. Finally, I would note that foreign exchange also negatively impacted operating margin by 40 basis points. Let me now turn to slide number seven and talk through our Applied Water segment. While revenue was up 2% overall, organically, we were down 1%.

Regionally, we saw growth in emerging markets more than offset low single-digit declines in the U.S. and Europe. I'd summarize our revenue performance as follows. Building service applications declined 2% due to continued weakness in the commercial building market, specifically within the institutional building sector, as I mentioned earlier. Our European residential business declined double digits due to continued market softness in the south. The weakness in Europe was only partially offset by growth in the U.S. residential market, which was against double-digit growth last year. Finally, I would highlight the continued strength in China drove modest emerging market growth against what was also a tough comp last year. Operating margin expanded 100 basis points to 14.4% year-over-year. We were able to offset volume declines through disciplined cost management and restructuring savings. Now let's turn to slide eight, where I'll cover the company's financial position.

Xylem maintains a strong cash position with a balance of $450 million at the end of Q2, with approximately 80% held outside of the U.S., consistent with our geographic business mix. Our net debt to net capital ratio is a healthy 26%, and our commercial paper and revolving credit facilities remain in place and continue to be unutilized. We remain committed to our balanced capital deployment strategy, which is to maintain and grow the business while enhancing shareholder returns through dividends and share repurchases. Over the first half of the year, we invested $48 million in capital expenditures, and we returned $147 million to shareholders, which reflects a 10% increase in dividends per share and $100 million under our share repurchase program. Over the first six months of the year, we generated $50 million of free cash flow.

This reflects typical seasonality and working capital dynamics, which include an increase in receivables due to the timing of Q2 sales and certain projects and increased inventory ahead of the second half ramp in revenue. Relative to the prior year, our free cash flow performance improved by $48 million. Please turn to slide nine, and I'll turn it back over to Patrick to cover our 2014 guidance.

Patrick Decker
CEO, Xylem

Thanks, Mike. Let's start with the top line. We still anticipate 2014 revenues of nearly $4 billion, which reflects organic growth of 2%-4%. We've increased our organic growth range at both the low and high end by a percentage point of growth. For Water Infrastructure, we expect organic revenue growth of 3%-4%, higher than our previous expectations and primarily reflecting higher project revenue in emerging markets. For Applied Water, we expect revenues to be flat to up 1% organically, reflecting our first half performance and soft end market outlook. This reflects a slight downward revision to our previous guidance. I will also note that the revenue range already reflects the reduction in revenue attributable to the U.K. valve business we divested. After posting 3% organic growth through the first six months, we expect second half organic revenue to be flat to up approximately 2%.

This range takes into consideration the relatively short cycle nature of our business and mixed strength in our end markets. It is important to note that our second half performance will be against tougher year-over-year comps. Segment margins are anticipated to be in the range of 14.2%-14.6%, and operating margins are projected to be in the range of 12.8%-13.2%. We anticipate earnings per share of $1.90-$2, excluding 2014 restructuring and realignment costs of approximately $40 million-$50 million. This reflects a $0.05 increase to the lower end of our range. Let me provide you with some perspective on this. We feel good about the execution of our broad-based restructuring actions this year, from which we now expect to achieve savings of $17 million.

This is in addition to the carryover savings of $25 million from the actions executed in 2013, bringing total savings to $42 million. We also feel good about our first half performance and have reflected our outlook for the second half, which includes some mixed end market dynamics, lower benefits from FX, and the U.K. valve divestiture. Let me provide some additional highlights around our end market outlook. Please turn to slide 10. This slide summarizes our expected 2014 organic revenue performance by end market. Let me spend a few minutes providing some perspective on our first half performance, our expectations over the second half, and what that all means from a full year perspective. Beginning with industrial, our largest end market, representing 45% of total revenues. Through the first half, we saw organic revenue up 3% and expect second half performance to be up low single digits.

Full year organic revenue growth is expected to be in the range of 1%-3%. Included in our second half expectation is sequential growth acceleration in the U.S. and continued growth from emerging markets. We are also assuming that Europe remains stable. Public utility, at 34% of total revenue, is our second largest market. Through the first half, we saw organic revenue up 6%, but expect second half organic performance to moderate considerably. This reflects tougher year-over-year comps and the timing of project deliveries. With that said, we expect second half revenue to be flat to up low single digits, and therefore, our full year expectation is in the range of 2%-5%. This outlook is improved relative to our original expectations and reflects the positive performance realized over the first half and our project backlog over the balance of the year.

As a reminder, due to the considerable lead time for most CapEx projects, the majority of project orders received over the second half of the year will deliver in 2015 and beyond. I would highlight that leading indicators and market commentary suggest improving market conditions, which is supported by our growing pipeline of projects. Moving to commercial, which represents approximately 11% of our revenue, we are revising our full year outlook for commercial downward. While we originally expected low single-digit growth, we now anticipate flat organic revenue performance. The revision downward reflects our first half organic revenue decline of 1% and only a modest improvement in the back half. Our overall performance reflects our overweight position to the weak U.S. institutional building market. We no longer expect this sector to recover meaningfully in 2014.

We do expect new product launches and strength in emerging markets to drive low single-digit growth over the second half. There is no change to our residential market outlook. We still expect low single-digit growth driven by the U.S. housing recovery. However, we do expect that growth in the U.S. will moderate over the second half, and that continued weakness in Europe will at least offset second half growth. Lastly, while it's only 3% of our business, we expect full year ag revenue to be flat year-over-year. This is down slightly from our previous expectations. Please turn to slide 11, and I'll turn it back over to Mike to cover some additional details on the guidance.

Mike Speetzen
CFO, Xylem

Thanks, Patrick. I'd like to spend a minute calibrating everyone on the call around what we expect our revenue and operating income profile to be over the balance of 2014. I'll begin with some comments around our shippable backlog. Of the total $816 million in backlog, $643 million is shippable in the second half, and the remaining $173 million is expected to ship in 2015. Third quarter shippable backlog is approximately $445 million and represents around 45% of our expected third quarter revenue. We still have a lot of book and turn business to deliver in a quarter when Europe is on holiday. For revenue, we see the second half profile more similar to 2011 and 2012, down sequentially in the third quarter with a ramp-up in the fourth quarter.

More specifically, we expect revenue to decline in Q3 2%-3% sequentially from the second quarter, reflecting the impact of European shutdowns in July and August and the typical second quarter peak within our Applied Water segment. By segment for Q3, we expect Water Infrastructure to be flat sequentially, and Applied Water is expected to decline sequentially approximately $30 million, again, reflecting its typical seasonal profile and the impact of the valves divestiture. Operating income performance over the second half will be driven by volume and incremental cost improvements in areas such as global sourcing and Lean, but will also be negatively impacted by mix and price. We see third quarter margins improving sequentially from the second quarter by 80-130 basis points, despite the expected volume decline. This performance reflects the savings we expect from the restructuring actions executed earlier this year.

We're now on track to deliver $42 million in restructuring savings, which includes approximately $20 million in savings in the second half. By segment, we expect the sequential margin improvement to be more pronounced in Water Infrastructure than within Applied Water. We expect full-year corporate expense of approximately $55 million, and our full-year operating tax rate is expected to be approximately 21%. Lastly, our fully diluted share count is expected to be approximately $185 million. With that said, please turn to slide 12, and let me hand the call back over to Patrick for some final comments. Patrick?

Patrick Decker
CEO, Xylem

Thanks again, Mike. Just a few comments before we get to Q&A. As you know, this year is a critical one for Xylem. We have begun to establish a track record of financial performance while also focusing on prospects for long-term growth. While we still have a lot of work to do, I am encouraged by our performance to date. We're making progress and are improving our productivity and efficiency. We have many growth opportunities to pursue, and we're doing the hard work now to be able to take advantage of the best ones to grow our leadership position in the world of water. Operator, we can now begin the Q&A session.

Operator

The floor is now open for questions. At this time, if you have a question or comment, please press *1 on your touchtone phone. If at any point your question is answered, you may remove yourself from the queue by pressing the # key. Again, we do ask that while you pose your question, that you pick up your handset to provide optimal sound quality. Thank you. Our first question is coming from Scott Davis with Barclays.

Scott Davis
Analyst, Barclays

Hi. Good morning, guys.

Patrick Decker
CEO, Xylem

Good morning, Scott.

Scott Davis
Analyst, Barclays

Off to a good start, Patrick, so congrats on that.

Patrick Decker
CEO, Xylem

Thank you.

Scott Davis
Analyst, Barclays

There's a few things I want to dig into, and I'm guessing that there's enough questions in the queue that you'll get to it, but can you talk a little bit about public utility in the U.S.? It's still flat against pretty easy comps, and is there an outlook there? When I talk to some of the local guys, they say there's pent-up demand for projects and such, but are you seeing anything that's tangible that would lead you to believe that business gets better?

Mike Speetzen
CFO, Xylem

Scott, this is Mike. There's a couple things going on. If you remember from some of the commentary we had last year, we actually saw a decline in the, what I'll call the longer-term bookings for our treatment business, project business, in the U.S. last year. Essentially, we see that carrying through in the current year shipping results. The good news is we are seeing the project activity picking up, and we're starting to build backlog in that business, and less about just the U.S., but overall, if you think about that backlog headed into 2015, we're up 18%, and when you look specifically at Water Infrastructure, we're actually up 22%. That's a very good indicator that things are at least starting to move in the right direction. The pipeline of bid and quote activity is at an all-time high.

It's clear that there is definitely activity starting to move from a U.S. standpoint.

Patrick Decker
CEO, Xylem

I would just add to that, Scott, that what I'm also seeing, and we're seeing is that as we integrated our front end of the business, I would say our treatment business is one of the businesses that's probably benefiting the most in terms of getting more at bats through the visibility that our transport and other businesses provide to them by now having an integrated front end. Our bidding activity on the pipeline is also improving.

Scott Davis
Analyst, Barclays

Okay. I wanted to ask you guys about M&A. When I think about legacy, well, over the years, just this business when it was within ITT, always talked about M&A, but M&A was always a little disappointing, I think, and there hasn't been a lot. I think the volume of transactions overall on this side of the business has been pretty light. How do you reinvigorate it, and how do you, when you say reactivating M&A pipeline, how do you do it when you're limited really to the concept of water?

Patrick Decker
CEO, Xylem

Sure.

Scott Davis
Analyst, Barclays

I'll just leave it there.

Patrick Decker
CEO, Xylem

Sure, no problem. Well, first, I've spent considerable amount of time with the team redoing the pipeline. It is a pretty healthy pipeline from my perspective and based on what I've seen. As you know, Scott, it is a fairly fragmented industry. I think we've said that certainly we're not going to be dogmatic on water. Obviously, we want to make sure that we don't stray from our identity here. Now that we've defined our three fields of play, that being water productivity, water quality, and the resiliency of Water Infrastructure, those are three pretty broad spectrums in the space of water, and that also opens up the opportunity to fill the pipeline. I do expect that, certainly early on here, the acquisitions that we do are going to be bolt-on. They're going to be close to the core.

Obviously over time, as we continue to expand, that brings into play more meaningful acquisitions.

Scott Davis
Analyst, Barclays

Okay. I'll pass it on. Thank you, guys.

Patrick Decker
CEO, Xylem

Thank you.

Mike Speetzen
CFO, Xylem

Thanks, Scott.

Operator

Our next question comes from the line of Deane Dray with Citi Investment Research.

Deane Dray
Analyst, Citi Investment Research

Thank you. Good morning, everyone.

Patrick Decker
CEO, Xylem

Good morning, Dean.

Mike Speetzen
CFO, Xylem

Morning.

Deane Dray
Analyst, Citi Investment Research

I was hoping to get some additional color on what I would call your high-quality problem of explaining how organic revenue growth, instead of coming at the low end of the range that you said back in May, came in at the high end. Patrick, you did give some good specifics, but just give us in context. You've got shorter cycle business, a little more limited visibility. Through April, maybe that's 30% of the quarter, you made that announcement. What are the other dynamics in terms of, can you quantify how much business got pulled in from July? Did you just convert more orders at the time into revenues? What does it say about your forecasting on a go-forward basis?

Mike Speetzen
CFO, Xylem

Yeah, Dean, this is Mike. Let me provide some comments. Then Patrick can certainly weigh in. I think there's a couple things. One, we were providing perspective on what we were seeing, and at the time, April was coming in essentially flat with where we were last year. I'd say that the short cycle nature of the business obviously does create a bit of a challenging dynamic from that standpoint. I think we hit some of the points in the prepared comments that as we progress through the quarter, we start to see the market improve, not substantially, but just enough to move us into that higher end of the range that we've been talking about.

More importantly, I think what you saw from us is the same thing you've seen for the past several quarters, which is we have much deeper visibility into the business now. The change that we made organizationally, we are now dealing directly down, say, at the dewatering level or the treatment level, we're able to react more quickly. Patrick and I came back from seeing the April results and really pushed the team around, making sure that we were cleaning up any of the delinquent shipments that we had, making sure that we were converting on all the orders that were to be shipped within the quarter. There wasn't anything large, notable that we pulled in, per se. I would say that the team worked hard to make sure that we met the commitments that we had laid out.

Deane Dray
Analyst, Citi Investment Research

Is this the calibration that book and ship is about 70% of your business, 30% project? Is that a fair split?

Mike Speetzen
CFO, Xylem

Yeah, I'd say right now, Dan, it's probably 70%-80%. Obviously as we see the longer-term orders improving, that dynamic's going to start to shift probably closer to that 70% mark over time. I'd say the short cycle nature of things like our rental dewatering business, those still weigh pretty heavy on the results and are areas where we try and stay as close as we can. We've developed some new processes for monitoring what we would term backlog in those businesses to give us better indicators around what the trajectory looks to be, but they're still short cycle in nature.

Deane Dray
Analyst, Citi Investment Research

Great. Then just in terms of the businesses, what I thought was very interesting in your release, you talk about this win in Brazil, it's noteworthy on a number of points. Importantly, and maybe give us some context, are these types of whole system high-end project bidding that you'd like to do more of? I'm pretty sure I heard Patrick call it a referential win. Does this qualify as a reference site? Maybe some of the economics when you're putting in one of these reference sites, because it becomes a showcase for the ability to do similar projects elsewhere. A little color there would be helpful.

Patrick Decker
CEO, Xylem

Sure, Dan. These absolutely are the kind of things that we would like to be involved in. You find, and from my background and experience, certainly in the developing markets, our customers and clients do tend to look at, I wouldn't call it complete turnkey solutions, but certainly looking at bundling services and technology. I think that's where we've already seen some of the biggest impact on the integration of our front end. I would say that in a number of those markets, the front end of our commercial organization has long been integrated. They've been working together for quite some time. These are long processes, you can appreciate, to come to closure and win a victory. We call it referential, I think, because these are key accounts. We don't share too much on the customer specifics and economics for obvious competitive reasons.

Mike Speetzen
CFO, Xylem

These are healthy projects. They bring with them a very attractive aftermarket service component to it as well. More importantly, it demonstrates that we've got the capability in these emerging markets when we focused on them. Secondly, it helps build the Xylem brand name. Not that we're always leading with that brand name in all cases, but it certainly increases our recognition of our brand in those developing markets.

Deane Dray
Analyst, Citi Investment Research

Great. The membranes, is that part of the joint venture with GE?

Mike Speetzen
CFO, Xylem

Yes, it is.

Deane Dray
Analyst, Citi Investment Research

Terrific. Thank you.

Patrick Decker
CEO, Xylem

Thank you.

Thanks, Dan.

Operator

Our next question comes from the line of Ryan Connors with Janney Montgomery.

Ryan Connors
Analyst, Janney Montgomery

Great. Thank you. I had a question for you, Patrick, on kind of the portfolio review in the U.S. I guess the fact that you're moving on to South America kind of suggests that some of your initial tour in the U.S. is done. Can you kind of give us your comments and perspective on how you believe the company's positioned in terms of the U.S. manufacturing footprint and whether you're satisfied with where you're at there, or whether you believe there's consolidation opportunities domestically?

Patrick Decker
CEO, Xylem

Sure. I think that over time, this is a multi-year journey, where we're trying to integrate a number of legacy standalone businesses. I would say that we've historically probably not had a comprehensive manufacturing strategy across the various businesses that we've got, whether that be in the U.S. or whether that be globally. That is an area that will be a focus for me and the team is to better understand what those opportunities are from our supply chain globally, but certainly specifically here in the U.S. as well. I think as I talk a lot about the emerging market opportunity, which I think is large and real, at the same time, that's not to suggest that we don't also have meaningful growth opportunities in the more mature, established markets.

Mike Speetzen
CFO, Xylem

I think there's an opportunity for us to drive more improvement on the aftermarket piece of our business. It's not as applicable to all of our businesses, but certainly some of them have a very attractive aftermarket opportunity that I don't believe that we fully mined. I would say something that I've spoken a lot about, and that is I see consistently across the company, there are further opportunities for lean deployment certainly here in the U.S. across not only our factories, but the entire value chain.

Ryan Connors
Analyst, Janney Montgomery

Okay, great. Another kind of more tactical question on pricing environment. I'm hearing less about it in your prepared remarks than we were 6, 12 months ago. I guess we can read that as a positive that the pricing environment has improved a little bit or at least isn't negative. Can you kind of give us an update on the pricing environment out there and the outlook?

Mike Speetzen
CFO, Xylem

Yeah, Ryan, so it's Mike. We're still seeing what I'd say is a negative bias from a pricing standpoint, more particularly in our Water Infrastructure business. Applied Water still is in a positive territory, although not at the same levels. I'd say a good portion of that's really more commodity pricing driven. I would say that the dynamics really haven't changed a lot. I think you can hear it with many of our competitors that the markets are improving, but we're all still in a much more slow growth environment than we have historically been. The competitive dynamics are such that it's still putting a negative bias on pricing. You're not hearing a lot of it in our prepared remarks because it's in line with expectations we had of somewhere in the 25-50 basis points of pressure coming out of that particular segment.

Ryan Connors
Analyst, Janney Montgomery

Okay, great. Well, that's very helpful, congrats on a great quarter and safe travels, Patrick.

Patrick Decker
CEO, Xylem

Thank you very much. Thanks.

Operator

Our next question comes from the line of Mike Halloran with Robert W. Baird.

Mike Halloran
Analyst, Robert W. Baird

Good morning, everyone.

Patrick Decker
CEO, Xylem

Hey, Mike.

Mike Halloran
Analyst, Robert W. Baird

Could you help frame the sourcing opportunity today, where it stands on a percentage basis? What kind of targets you might be putting out there? Maybe better put, who are you looking at from a peer group perspective? What kind of ranges do they have from a guidance perspective, so we can see kind of where you think you guys can go over time?

Patrick Decker
CEO, Xylem

Sure. Well, I think it's probably too early to tell right now exactly to put a number out there as to what I think the global sourcing opportunity is. I think that it's probably better to talk about the journey as to where we're coming from and where we're going. Certainly don't want to suggest that there's never been any kind of leverage gained across the businesses. Each one of the value centers and the businesses in them have historically operated on a standalone basis in terms of having their own procurement functions. We have a number of categories that clearly, if we leverage our global spend here, there's meaningful upside to be gained in doing that. Secondly, it's not just about the cost takeout, but it's also about getting better quality, better service, better delivery from our suppliers.

It really, again, is the whole value chain from a sourcing standpoint. I think there are a number of companies that are out there, obviously, that we model against and put ourselves up against as a benchmark. Certainly the Danaher's of the world, the Roper's of the world, a few others that are out there that I think have been on that journey, and really have delivered quite a value by standardizing their processes across areas, including procurement.

Mike Halloran
Analyst, Robert W. Baird

That's fair. On the dewatering side, a couple things there. Just one, what kind of rental utilization levels are you guys seeing now? Or at least how have those tracked as you look through the quarter? Sounds like the oil and gas piece in particular is starting to strengthen up here. What's the customer cadence sound like, and what's the trajectory look like as you look out a little bit farther?

Patrick Decker
CEO, Xylem

Yeah, Mike, the cadence has been improving pretty much starting back in late February. We've seen that continue now through the second quarter and obviously continue to monitor that. Utilization rates, they're not at what I'd call the peak yet. That's a broad comment because we have obviously model mix within that we continue to watch. But I would say we're getting up around that 50% mark, which is pretty close to getting to optimal. So, we'll be moving into the decision around what additional assets do we need to contemplate, which would be a good thing to start talking about.

Mike Halloran
Analyst, Robert W. Baird

Thanks for the time, gentlemen.

Patrick Decker
CEO, Xylem

Thank you.

Operator

Our next question comes from the line of Matt Summerville with KeyBank.

Matt Summerville
Analyst, KeyBank

Morning. Just a follow-up on the dewatering business. Can you talk about how much that was up in Q2, whether June in particular was stronger than you would've thought, what your expectations are for the back half?

Mike Speetzen
CFO, Xylem

Yeah. Matt, we saw dewatering kind of on a sequential improvement. Like I had mentioned when I was answering Mike's question, we've seen that kind of improving month to month. In the second quarter, we were up 4%, that brought our first half up, call it mid-single digits. That's vast improvement over the anemic growth that we had in the first quarter. We see that trend continuing. We're optimistic given the strength we've seen in hydraulic fracturing and just overall what looks to be a rebound in construction and use in the public utility market should support that continued growth through the balance of the year.

Matt Summerville
Analyst, KeyBank

With respect to the Applied Water business, I guess whether you talk industrial, commercial, residential, maybe sticking with those three buckets, you've been sort of down here in this business for a little while organically, it doesn't sound like your construction oriented business is picking up yet. I guess, what can you say to sort of give us confidence that you're not losing market share in these businesses?

Patrick Decker
CEO, Xylem

Yeah. Well, as you probably know, in these businesses, market share data is not always easy to get. Certainly all of the indications that we've got right now, we've been asking ourselves that question with the teams is that actually, when you look at some of our other companies that have reported in the space, if anything, we've probably certainly held, if not even possibly gained some ground, especially in areas like groundwater, et cetera. We don't really comment on share positions and really comment on our competitors, but we certainly don't have any reason right now to believe that we've lost any share.

Matt Summerville
Analyst, KeyBank

Patrick, just one final one. Similar to how you talked about your U.S.-based footprint, what's your initial appraisal of the manufacturing footprint you guys have in Western and Northern Europe?

Patrick Decker
CEO, Xylem

Sure. Well, again, I think it's early assessment. I think that one of the areas that is fairly apparent to me, and that is certainly when I think about the needs that we have to be able to accelerate our growth in a number of the developing markets

There's only so far that we're able to go by relying upon, in some areas, an import model. We already have some footprint in some of our developing markets, but I would say we will expand that footprint over time. Obviously, over time, we'll evaluate what our needs are from a global supply chain and make the changes necessary at that point.

Matt Summerville
Analyst, KeyBank

Thanks, guys.

Patrick Decker
CEO, Xylem

Yeah. Thank you.

Mike Speetzen
CFO, Xylem

Thank you.

Operator

Our next question comes from the line of Joe Giordano with Cowen.

Joseph Giordano
Analyst, Cowen

Hey, guys. Thanks for taking the questions.

Mike Speetzen
CFO, Xylem

Hey, Joe.

Joseph Giordano
Analyst, Cowen

On the quoting activity on the muni side, I guess you're focused on U.S. and Europe. Just curious as to how competitive that's been. I know in Water Infrastructure you say price has been a headwind. When you're saying quoting activity is picking up, does the level of competitiveness there seem to be exacerbating pricing pressure?

Mike Speetzen
CFO, Xylem

Yeah, I'd say it's a fair characterization of the market. I wouldn't put the pricing pressure as a huge dynamic at this stage. I think the competitive environment is certainly there, but I think folks are being smart about the pricing dynamics. I think that coupled with the fact that commodity prices have been relatively tame over the past year, really has lowered our ability to get additional price. I think the important thing to remember is we're still priced at a premium relative to the competition. We're getting the growth. We may be losing a little bit on the pricing side, but overall, it's still a pretty positive equation for us.

Joseph Giordano
Analyst, Cowen

Okay. Then on the restructuring side, you mentioned the savings you expect for the full year, on top of what you got last year. Where are we at as of one half? I'm not trying to pin you down for next year kind of guidance, but this year you're saying, we're talking about 20% or so EPS growth on around 4% revenue, a lot of restructuring savings. How would you categorize broadly what your expectation is? Would next year be characterized more of a revenue-driven year or more of a restructuring cost-out type of year?

Mike Speetzen
CFO, Xylem

Yeah. Let me answer the more tactical side, and then I'll let Patrick provide a perspective as we look forward. Through the first half, we've incurred about $18 million worth of restructuring costs, and the savings that we've racked up is about $22 million, and big portion of that $22 million is actually the activity we had underway last year. For the second half, we're guiding around $20 million of savings, and that's largely due to the actions that we've taken through the first half, relative to that $18 million of cost. I would think about that going into next year as probably about an $18 million-$20 million tailwind, as we lap and get pickup favorability essentially in the first half of next year from the actions that we will have executed.

Then, Joe, just to remind you, we are guiding $30 million-$35 million of total restructuring costs this year. You can see that we still have a ways to go in the second half.

Joseph Giordano
Analyst, Cowen

Yeah

Mike Speetzen
CFO, Xylem

$12 million-$17 million. With that, I'll turn it over to Patrick for any comments relative to as we look out to next year.

Patrick Decker
CEO, Xylem

Sure, yeah. Obviously, staying well short of giving any kind of guidance or signal on 2015. I think certainly, we are very much focused on how do we accelerate the growth of the business. Obviously, that will not be at the expense of margins. We're looking at healthy, profitable growth. Certainly, we're making sure we're making the investments there to drive the top line. Secondly, we will continue to maintain the focus on the cost side and the margin side. While I would never rule out restructuring, our focus right now really again, is on ramping up, again, the continuous improvement opportunities in global sourcing and lean. We certainly would expect margin expansion to continue from those areas, but it's going to be a balanced look as we go forward from 2015 onward.

Joseph Giordano
Analyst, Cowen

Okay, great. If I can sneak just one fast one in. If M&A, if you don't find anything attractive in the second half, would that imply potentially more repurchases at the levels we've seen in the first half?

Patrick Decker
CEO, Xylem

I think it's premature right now for me to comment on that. Certainly, we feel good about the return to shareholders that we've already committed to. We'll have more to comment on that as we get further along on the M&A assessment. Obviously, M&A opportunities, you can fully appreciate, take time to cultivate. Us having kind of reignited that, it may take a little bit of time, but we feel good about the prospects and we'll have more to comment.

Joseph Giordano
Analyst, Cowen

Great. Thanks, guys.

Patrick Decker
CEO, Xylem

Thank you.

Mike Speetzen
CFO, Xylem

Thank you.

Operator

Our next question comes from the line of Nathan Jones with Stifel.

Nathan Jones
Analyst, Stifel

Morning, Patrick, Mike, Phil.

Patrick Decker
CEO, Xylem

Good morning.

Mike Speetzen
CFO, Xylem

Morning.

Nathan Jones
Analyst, Stifel

Patrick, we've been talking about several things here that are probably going to take some investments. Ramping up on Lean Six Sigma, we've talked about 200 basis points, potentially of SG&A coming out. You talked today about localizing manufacturing, global sourcing investments. Can you talk about whether we should be expecting some increased CapEx over the next year or two, and what impact that might be seen on the margin line as well?

Patrick Decker
CEO, Xylem

Sure. I think that one of the things that we're very much driving here in the company right now is kind of what I call a productivity for growth mindset. That is, again, given where we are in our Lean deployment, global sourcing, some of the other restructuring benefits we're getting from the actions taken. These are all intended not only to expand margins, which you're seeing obviously here in 2014, and will continue in 2015. Part of those savings go to fund some of these investments that we're talking about. I don't think that we should be looking at any kind of dilution in margin. As we go forward, we'll continue to expand margins, as well as continue to accelerate the top-line growth, assuming the markets cooperate.

Nathan Jones
Analyst, Stifel

If we could just take a look at specifically on Lean Six Sigma With what you've seen since you've been at the company, can you talk about where we are in terms of Lean deployment? How long you think it's going to take until you're at a reasonable level?

Patrick Decker
CEO, Xylem

Sure. I think that the way I would characterize it is we've got pockets of excellence right now across the company, and I think that's clearly a reflection of the fact that these businesses historically had been, I think, early adopters of Lean Six Sigma, other continuous improvement tools. My assessment, and I think the assessment of many of the people in the company, is that during the transition of the spin, other things going on, some of those things began to fade. I think historically, the focus had predominantly been on inside the four walls of the factory, so very much focused on cost takeout, et cetera, in the factories themselves. I think the opportunities here are not only to now reignite that in the factories, but more importantly, to apply these tools across the entire value chain.

Speed to market, efficiency, transactions, back office, but also using these tools to help us get at what our overall global manufacturing strategy is going to be. I look at this in a bigger picture rather than just applying lean within any given factory. That to me is where the big opportunities lie.

Nathan Jones
Analyst, Stifel

Yeah, makes sense. Could you possibly quantify, you said pockets of excellence, what percentage of the portfolio you describe as excellent and what percentage of the portfolio you think needs a significant amount of work?

Patrick Decker
CEO, Xylem

Yeah, that's a tough one to say because we've got such a distributed footprint across the board. The way I'd characterize it, I'd say probably at about a third of the locations that I've been to, I've seen a pretty heavy adoption of classic tools being deployed. I think, the whole point of continuous improvement in lean is that it is a journey. It never ends, and you're always kind of revitalizing and refreshing things. There's opportunities all over the place. I think that there's probably still two-thirds of the organization that I think are still fairly early on in the whole process.

Nathan Jones
Analyst, Stifel

That's helpful. Thanks very much.

Patrick Decker
CEO, Xylem

Okay.

Mike Speetzen
CFO, Xylem

Thanks, Nathan.

Operator

Our next question comes from the line of Kevin Max with BB&T Capital Markets.

Kevin Max
Analyst, BB&T Capital Markets

Thanks. Good morning.

Patrick Decker
CEO, Xylem

Good morning, Kevin.

Mike Speetzen
CFO, Xylem

Good morning.

Kevin Max
Analyst, BB&T Capital Markets

Just to follow up on that last question. Even with some additional spending that you may be planning for productivity and footprint and other things, is it still the way we should be thinking about this in terms of incremental margins, that we ought to normalize into something in the low 30s as we get out beyond the second half of this year?

Mike Speetzen
CFO, Xylem

Yeah, I think so, Kevin. I think largely speaking, we want to hold to the guidelines that we've provided around the incrementals, as well as when you think about our capital expenditures, we've pulsed 2.5%-3% of revenue. We may have one-off investments that we have to make, and we'd obviously provide clarity around that. We think we can largely handle it within those guideposts. I think it's back to Patrick's comments around productivity for growth and making sure that we've got an engine that can produce the room to make the investments to keep the growth going.

Kevin Max
Analyst, BB&T Capital Markets

The first half was, of course, very strong, up around 60%, and we all know that'll normalize. Can you just give a little more color on the incremental margin guide for Q3? It looks like that's actually doing more than normalizing. It's quite a bit below the normal range.

Mike Speetzen
CFO, Xylem

Yeah. I think when you think about the third quarter, sequentially, we're going to be down 2% to 3% from a revenue standpoint. We're actually expanding margins 80 to 130 basis points. That's largely due to the fact that we've got the incremental restructuring kicking in the back half. We're also driving additional sourcing and Lean initiatives to try and improve the gross margin as we head into the back half.

Kevin Max
Analyst, BB&T Capital Markets

Okay, there's some additional spend that's happening on things like sourcing and Lean that wasn't happening at the same magnitude in the first half?

Mike Speetzen
CFO, Xylem

There's a little bit. You can see it, I'll use the corporate line as an example. We've guided to a $55 million full-year corporate number, which is slightly above the run rate coming out of the first half. Given the weakness we saw coming out of January and February with the weather, we obviously, like we did last year, we took some actions to move things around within the year. Given where we're at, we feel confident that we can move forward with those initiatives in the back half. I think, Kevin, the important thing to note when you compare whether you're looking at Q3 versus last year or the second half versus last year, you have to really look back at 2013, first and second half, because they were really a tale of two different halves.

That first half of last year, we were looking at a negative 5% growth rate and pretty heavy decremental margins in areas like Europe and dewatering. The second half of 2013, not only did we have positive organic growth, which we got volume leverage out of in areas like Europe and dewatering, but on top of that, we got the positive benefits of all the things we had done in terms of the restructuring actions that improved us incrementally from first half to second half. There is a bit of that compare that plays into it. You have the challenge that we're facing in the back half of 2014, which is primarily around things like pricing and then the timing of the investments throughout the year.

Kevin Max
Analyst, BB&T Capital Markets

Okay. Just finally, Mike, since you mentioned the corporate line, that's tracking in the first half well below that guide. Is it still a $55 million-$60 million outlook you have there on that line?

Mike Speetzen
CFO, Xylem

Fifty-five.

Kevin Max
Analyst, BB&T Capital Markets

55. Okay. Thank you.

Mike Speetzen
CFO, Xylem

Yep. You bet.

Operator

Our next question comes from the line of Brian Konigsberg with Vertical Research.

Brian Konigsberg
Analyst, Vertical Research

Yes. Hi, good morning.

Patrick Decker
CEO, Xylem

Good morning.

Mike Speetzen
CFO, Xylem

Hi, Brian.

Brian Konigsberg
Analyst, Vertical Research

Right. Actually, just coming back a little bit to the Applied Water line. You talked about the market just being generally difficult, but you don't think you're losing share. Just on residential, it doesn't seem like that ever really got off the ground much, very significantly at all. Now you're saying that it's still going to be fairly flat. Is it just the nature of the business that it's more replacement that never really went away? Why is that not stronger? Maybe give a little more color on why it just never saw any benefit through the upturn of that cycle.

Mike Speetzen
CFO, Xylem

Yeah. Brian, I guess I'd point back to some of the stats. First and foremost, we actually saw 6% growth last quarter in the residential market. If you look at last year, the second quarter, we actually posted 6% growth. Some of it is compares and timing in the cycle. I'd also say we're not as exposed to all the new construction and some of the things that are driving the improvement in the residential market. The majority of our business is really focused around ground well and circulator pumps that go on boilers. It's a bit of a more niche-y play, but we have seen some of the positive effects of the residential recovery overall. I think you've seen that play out in different quarters throughout the course of the last couple of years.

Brian Konigsberg
Analyst, Vertical Research

Okay, just on the commercial side, it's weak kind of in the near term, do you anticipate you'll participate if that starts to gain traction, or is it a similar type of dynamic?

Mike Speetzen
CFO, Xylem

Well, I think we'll participate, but again, it's going to be driven by a couple of different things. One, the institutional market, specifically in places like the U.S. We think we're aligning well in the emerging markets, China in particular, to take advantage of what could be the resumption of the commercial build-out.

Brian Konigsberg
Analyst, Vertical Research

I got you. I just wanted to clarify, did you quantify the revenue pull forward from the project shipments this quarter? I know you talked to it. I didn't hear a specific number, unless I missed it.

Mike Speetzen
CFO, Xylem

No, there wasn't anything notable or material that we would point to.

Brian Konigsberg
Analyst, Vertical Research

Okay. All right, great. Thank you very much.

Mike Speetzen
CFO, Xylem

Thank you.

Brian Konigsberg
Analyst, Vertical Research

Thank you.

Operator

Our final question comes from the line of David Rose with Wedbush Securities.

David Rose
Analyst, Wedbush Securities

Good morning. Thanks again for taking the call.

Mike Speetzen
CFO, Xylem

Good morning, David.

David Rose
Analyst, Wedbush Securities

A couple final ones. Going back to some of the metrics on lean and maybe on-time delivery. In the last quarter, you've improved it. Does this mean that your on-time delivery numbers have improved moving forward? Is this something structural that you did, or was this sort of an urgent effort to ship out everything? That's one. Two is if you can talk about some of the lean metrics about which we should measure outside of the four walls, particularly on the SG&A side going forward. What sort of productivity measures should we be looking at?

Patrick Decker
CEO, Xylem

Sure. On the first one, I would say this is right now pretty much brute force in terms of just people focusing on making sure that delinquencies are managed and handled. I wouldn't suggest there was any kind of big enhancement of lean deployment that drove that. That's certainly a long-term activity. Although, again, some of the businesses that were experiencing this are fairly far along in the lean journey. I wouldn't suggest it was all brute force, but largely so. In terms of metrics that are out there, not prepared to disclose any just yet. Certainly, a little bit further down the road here, I'll speak more openly and candidly around what are those big metrics that we're going to be measuring against.

There'll be some classic ones in there, and obviously, certainly as we go after further improvements in the area of SG&A, and particularly G&A, that will certainly be one of those metrics that we're focused on. The others are very much focusing on what our penetration in terms of our certification rates are, as well as the deployment of resources on active projects. We're fairly far behind, and that is a starting point. Again, as I mentioned before, the good news on this from a company standpoint is that this is not a foreign language for many people in the company. It's just a matter of reinvigorating the focus and deploying it beyond the four walls of the factory.

David Rose
Analyst, Wedbush Securities

Okay. That's helpful. Lastly, Patrick, given your background of highly engineered products and the aftermarket side, you hit upon it. What do you need to do? Maybe first of all, what is the number today with which you're working in terms of aftermarket as a percentage of total sales? What number do you want to get to, and what do you have to do to get there from an investment standpoint? Do you have to invest in some of those emerging markets a la Brazil and setting up the infrastructure there?

Patrick Decker
CEO, Xylem

Sure, it's a great question, and I'll have more to say here in future calls on exactly, again, what these goals and metrics are and some of the structural moves that we would be considering making here in the organization to get after that. Today, we do just below 40% in aftermarket if you consider the parts, the service, the replacement piece. That number, in my view, certainly needs to be higher than that. It's not just about the percentage itself and the profitability that you get in that business relative to the OEM, but it's also just the intimacy that you get with a customer by being in there with them and getting visibility of what's happening from a competitive standpoint as well.

I think that what we need to do in the area is obviously set some big goals and metrics, make sure that we're organized effectively to get at that. Right now, again, we do it very well in pockets, depending upon which value center that we're talking about. Secondly, I would say a big piece of this is making sure that as we go into ramping up our presence in some of the key emerging markets, we want to make sure that we really maintain control of our installed base and that we're also selling aftermarket as part of the initial sell rather than trying to chase it afterwards.

David Rose
Analyst, Wedbush Securities

Okay. Well, that's helpful. Thank you very much.

Patrick Decker
CEO, Xylem

Thank you. Thanks, David.

Operator

That was our final question. I'd like to turn the floor back over to Patrick Decker for any additional or closing remarks.

Patrick Decker
CEO, Xylem

Well, I just want to thank everybody for taking the time to join us this morning. We very much appreciate your support and interest, and I look forward to catching up with you and updating you on our progress in our next call. Between now and then, safe travels, and we'll talk soon.

Operator

Thank you. This does conclude today's Xylem Second Quarter 2014 Earnings Conference Call. Please disconnect your lines at this time and have a wonderful day.